{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:29:36Z","timestamp":1788172176835,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010031","name":"Postdoctoral Research Foundation of China","doi-asserted-by":"publisher","award":["2020M671550"],"award-info":[{"award-number":["2020M671550"]}],"id":[{"id":"10.13039\/501100010031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Carbamoyl phosphate synthetase I defect (CPS1D) is a rare disease with clinical case reports mainly in early neonates or adults, with few reports of first onset in late neonatal to childhood. We studied the clinical and genotypic characteristics of children with childhood onset CPS1D caused by two loci mutations (one of these is a rarely reported non-frame shift mutation) in the <jats:italic>CPS1<\/jats:italic>.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present a rare case of adolescent-onset CPS1D that had been misdiagnosed due to atypical clinical features, and further investigations revealed severe hyperammonemia (287\u00b5mol\/L; reference range 11.2\u2009~\u200948.2umol\/L). MRI of the brain showed diffuse white matter lesions. Blood genetic metabolic screening showed elevated blood alanine (757.06umol\/L; reference range 148.8\u2009~\u2009739.74umol\/L) and decreased blood citrulline (4.26umol\/L; reference range 5.45\u2009~\u200936.77umol\/L). Urine metabolic screening showed normal whey acids and uracil. Whole-exome sequencing revealed compound heterozygous mutations in the <jats:italic>CPS1<\/jats:italic>, a missense mutation (c.1145\u00a0C\u2009&gt;\u2009T) and an unreported de novo non-frame shift mutation (c.4080_c.4091delAGGCATCCTGAT), respectively, which provided a clinical diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A comprehensive description of the clinical and genetic features of this patient, who has a rare age of onset and a relatively atypical clinical presentation, will facilitate the early diagnosis and management of this type of late onset CPS1D and reduce misdiagnosis, thus helping to reduce mortality and improve prognosis. It also provides a preliminary understanding of the relationship between genotype and phenotype, based on a summary of previous studies, which reminds us that it may help to explore the pathogenesis of the disease and contribute to genetic counselling and prenatal diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01569-w","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T10:02:33Z","timestamp":1687773753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical and genetic analysis of a case of late onset carbamoyl phosphate synthase I deficiency caused by CPS1 mutation and literature review"],"prefix":"10.1186","volume":"16","author":[{"given":"Shangyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohuan","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiehen","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleem Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"1569_CR1","doi-asserted-by":"crossref","unstructured":"Zhang G, Chen Y, Ju H, Bei F, Li J, Wang J, Sun J, Bu J. Carbamoyl phosphate synthetase 1 deficiency diagnosed by whole-exome sequencing. J Clin Lab Anal. 2018;32(2):e22241.","DOI":"10.1002\/jcla.22241"},{"key":"1569_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00431-015-2644-z","volume":"175","author":"EZ Ali","year":"2016","unstructured":"Ali EZ, Khalid MKNM, Yunus ZM, Yakob Y, Chin CB, Latif KA, et al. Carbamoylphosphate synthetase 1 (CPS1) deficiency: clinical, biochemical, and molecular characterization in malaysian patients. Eur J Pediatrics. 2016;175:339\u201346.","journal-title":"Eur J Pediatrics"},{"key":"1569_CR3","doi-asserted-by":"crossref","unstructured":"Diez-Fernandez C, H\u00e4berle J. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder. Expert Opin Ther Targets. 2017;21(4):391\u20139.","DOI":"10.1080\/14728222.2017.1294685"},{"issue":"6","key":"1569_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/humu.21406","volume":"32","author":"J Haberle","year":"2011","unstructured":"Haberle J, Shchelochkov OA, Wang J, et al. Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations. Hum Mutat. 2011;32(6):579\u201389.","journal-title":"Hum Mutat"},{"key":"1569_CR5","doi-asserted-by":"crossref","unstructured":"Yang X, Shi J, Lei H, Xia B, Mu D. Neonatal-onset carbamoyl phosphate synthetase I deficiency: a case report. Med (Baltim). 2017;96(26):e7365.","DOI":"10.1097\/MD.0000000000007365"},{"key":"1569_CR6","doi-asserted-by":"crossref","unstructured":"R\u00fcegger CM, Lindner M, Ballhausen D, Baumgartner MR, Beblo S, Das A, Gautschi M, Glahn EM, Gr\u00fcnert SC, Hennermann J, Hochuli M, Huemer M, Karall D, K\u00f6lker S, Lachmann RH, Lotz-Havla A, M\u00f6slinger D, Nuoffer JM, Plecko B, Rutsch F, Santer R, Spiekerkoetter U, Staufner C, Stricker T, Wijburg FA, Williams M, Burgard P, H\u00e4berle J. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders. J Inherit Metab Dis. 2014;37(1):21\u201330.","DOI":"10.1007\/s10545-013-9624-0"},{"key":"1569_CR7","doi-asserted-by":"crossref","unstructured":"Bai R, He A, Guo J, et al. Novel pathogenic variant (c.2947C>T) of the carbamoyl phosphate synthetase 1 gene in neonatal-onset deficiency.\u00a0Front Neurosci. 2022;16:1025572. Published 2022 Oct 21.","DOI":"10.3389\/fnins.2022.1025572"},{"key":"1569_CR8","doi-asserted-by":"crossref","unstructured":"Choi R, Park HD, Yang M, et al. Novel Pathogenic Variant (c.580C>T) in the CPS1 Gene in a Newborn With Carbamoyl Phosphate Synthetase 1 Deficiency Identified by Whole Exome Sequencing. Ann Lab Med. 2017;37(1):58-62.","DOI":"10.3343\/alm.2017.37.1.58"},{"key":"1569_CR9","doi-asserted-by":"crossref","unstructured":"Talebi M, Yahya Vahidi Mehrjardi M, Kalhor K, Dehghani M. Is there any relationship between mutation in CPS1 Gene and pregnancy loss? Int J Reprod Biomed. 2018;17(5):371-4. Published 2018 Jun 13.","DOI":"10.18502\/ijrm.v17i5.4604"},{"key":"1569_CR10","doi-asserted-by":"crossref","unstructured":"Lin HT, Enchautegui-Colon Y, Huang YR, Zimmerman C, DeMarzo D, Tsai AC. Novel compound heterozygote variants: c.4193_4206delinsG (p.Leu1398Argfs*25), c.793C>A (p.Pro265Thr), in the CPS1 gene (NM_001875.4) causing late onset carbamoyl phosphate synthetase 1 deficiency-Lessons learned. Mol Genet Metab Rep. 2022;33:100942. Published 2022 Nov 26.","DOI":"10.1016\/j.ymgmr.2022.100942"},{"key":"1569_CR11","doi-asserted-by":"crossref","unstructured":"Sugiyama Y, Shimura M, Ogawa-Tominaga M, et al. Therapeutic effect of N-carbamylglutamate in CPS1 deficiency. Mol Genet Metab Rep. 2020;24:100622. Published 2020 Jul 8.","DOI":"10.1016\/j.ymgmr.2020.100622"},{"key":"1569_CR12","doi-asserted-by":"crossref","unstructured":"Yan B, Wang C, Zhang K, et al. Novel Neonatal Variants of the Carbamoyl Phosphate Synthetase 1 Deficiency: Two Case Reports and Review of Literature. Front Genet. 2019;10:718. Published 2019 Aug 22.","DOI":"10.3389\/fgene.2019.00718"},{"key":"1569_CR13","doi-asserted-by":"crossref","unstructured":"Fan L, Zhao J, Jiang L, et al. Molecular, biochemical, and clinical analyses of five patients with carbamoyl phosphate synthetase 1 deficiency. J Clin Lab Anal. 2020;34(4):e23124.","DOI":"10.1002\/jcla.23124"},{"key":"1569_CR14","doi-asserted-by":"crossref","unstructured":"Ishikawa R, Sugimoto T, Abe T, et al. A 36-year-old Man with Repeated Short-term Transient Hyperammonemia and Impaired Consciousness with a Confirmed Carbamoyl Phosphate Synthase 1 Gene Monoallelic Mutation. Intern Med. 2022;61(9):1387-92.","DOI":"10.2169\/internalmedicine.7961-21"},{"key":"1569_CR15","unstructured":"Imataka G, Ishii J, Ando Y, et al. Long-term survival of a patient with acute neonatal-onset metabolic encephalopathy with carbamoyl phosphate synthetase 1 deficiency. Eur Rev Med Pharmacol Sci. 2020;24(19):10051-3."},{"key":"1569_CR16","doi-asserted-by":"crossref","unstructured":"Zhou Q, Huang H, Ma L, Zhu T. The Application of Next-Generation Sequencing (NGS) in Neonatal-Onset Urea Cycle Disorders (UCDs): Clinical Course, Metabolomic Profiling, and Genetic Findings in Nine Chinese Hyperammonemia Patients. Biomed Res Int. 2020;2020:5690915. Published 2020 Aug 31.","DOI":"10.1155\/2020\/5690915"},{"key":"1569_CR17","doi-asserted-by":"crossref","unstructured":"Diez-Fernandez C, H\u00e4berle J. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder. Expert Opin Ther Targets. 2017;21(4):391-9.","DOI":"10.1080\/14728222.2017.1294685"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01569-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T10:04:22Z","timestamp":1687773862000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01569-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01569-w","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"18 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been performed in accordance with the Declaration of Helsinki and has been approved by the ethic committee of Children\u2019s Hospital Affiliated to Nanjing Medical University. Written informed consent to participate was obtained from patient\u2019s parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained informed written consent from the patient\u2019s parents for the publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}